Frequently Asked Questions About NeuroStar TMS Therapy

We know choosing a treatment can feel overwhelming, especially after years of trying different options. Below are answers to some of the most common questions we hear from patients in Jacksonville. If you do not see your question listed, please reach out and our team will be happy to help.

Does TMS therapy work for depression?

Yes. In a real-world outcomes study of NeuroStar patients, 83% experienced measurable improvement and 62% achieved full remission. The NeuroStar Outcomes Registry is the world’s largest for any MDD treatment over 17,700 patients across 118 practice sites.

Most major insurance plans cover TMS. We accept TRICARE, Medicare, Aetna, Cigna, UnitedHealthcare, Optum, and Blue Cross Blue Shield. Coverage typically requires an MDD diagnosis and 2 or more failed antidepressant trials. We verify your benefits before your first appointment.

Most patients feel a light tapping sensation on their scalp, not pain. Any discomfort typically fades within the first couple of sessions. There’s no sedation and no recovery time. You drive yourself home.

A standard course is 36 sessions over approximately 7 weeks, five days a week. Each session takes as little as 19 minutes. Many patients begin noticing improvement within the first two to three weeks.

Yes. NeuroStar is the only TMS device FDA-cleared for patients 15 and older with major depressive disorder. In 2024 clinical data presented at the AACAP annual conference, adolescent patients showed a 78% response rate and 48% remission rate.

No referral is required to schedule a free consultation. Most insurance plans do require documented prior antidepressant trials for coverage authorization — our team guides you through that process.

Our HIPAA-compliant E-Fax number for referrals is (904) 715-8753.

Please include the following minimal patient information: first/last name, DOB, address, contact number/email, diagnosis, insurance and policy number, and name of referring provider.